Semita I Nyoman, Utomo Dwikora Novembri, Suroto Heri, Sudiana I Ketut
Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Orthopaedic Department, Faculty of Medicine, Jember University, Jember, Indonesia.
Asian Spine J. 2023 Apr;17(2):231-239. doi: 10.31616/asj.2022.0152. Epub 2023 Jan 10.
Experimental animal study.
This study aims to investigate the effects of treatment with human neural stem cell (HNSC) secretomes on subacute spinal cord injury (SCI) post-laminectomy by analyzing interleukin-10 (IL-10), matrix metalloproteinase 9 (MMP9), transforming growth factor-β (TGF-β), and Basso-Beattie-Bresnahan (BBB) score locomotors as expressions of neurological recovery.
In the United States, SCI has a recovery rate of 0.08%, tetraplegia 58.7%, and paraplegia 40.6%. Therapeutic approaches to SCI have focused on modulating the secondary cascade to prevent neurological deterioration and glial scar formation. Increasing evidence has shown that the success of cell-based SCI therapy is attributed to the secretomes rather than the cells themselves, but the effect of treatment with HNSC secretomes in SCI is unclear.
This experimental study investigated 15 Rattus norvegicus rats that were divided into three groups: (1) normal, (2) SCI+nonsecretome, and (3) SCI+secretome (30 μL, intrathecal Th10). Model subacute SCI post-laminectomy was performed in 60 seconds using an aneurysm Yasargil clip with a closing forceps weighing 65 g (150 kdyn). At 35 days post-injury, the specimens were collected, and the immunohistochemicals of IL-10, MMP9, and TGF-β were analyzed. Motor recovery was evaluated based on the BBB scores.
The SCI post-laminectomy of rats treated with HNSC secretomes showed improvements in their locomotor recovery based on the BBB scores (p =0.000, mean=18.4) and decreased MMP9 (p =0.015) but had increased the levels of IL-10 (p =0.045) and TGF-β (p =0.01).
These results indicate that the factors associated with the HNSC secretomes can mitigate their pathophysiological processes of secondary damage after SCI and improve the locomotor functional outcomes in rats.
实验性动物研究。
本研究旨在通过分析白细胞介素 - 10(IL - 10)、基质金属蛋白酶9(MMP9)、转化生长因子 - β(TGF - β)以及巴索 - 贝蒂 - 布雷斯纳汉(BBB)评分作为神经恢复的表达指标,来研究人神经干细胞(HNSC)分泌组治疗对椎板切除术后亚急性脊髓损伤(SCI)的影响。
在美国,脊髓损伤的恢复率为0.08%,四肢瘫痪占58.7%,截瘫占40.6%。脊髓损伤的治疗方法主要集中在调节继发性级联反应以防止神经功能恶化和胶质瘢痕形成。越来越多的证据表明,基于细胞的脊髓损伤治疗的成功归因于分泌组而非细胞本身,但HNSC分泌组治疗在脊髓损伤中的效果尚不清楚。
本实验研究对15只大鼠进行了研究,将其分为三组:(1)正常组,(2)脊髓损伤+非分泌组,(3)脊髓损伤+分泌组(鞘内注射30μL Th10)。使用一把重65g(150kdyn)的动脉瘤夹Yasargil在60秒内对大鼠进行椎板切除术后亚急性脊髓损伤模型制备。在损伤后35天,收集标本,并分析IL - 10、MMP9和TGF - β的免疫组织化学情况。基于BBB评分评估运动恢复情况。
接受HNSC分泌组治疗的大鼠在椎板切除术后的脊髓损伤,基于BBB评分显示其运动恢复有所改善(p = 0.000,平均值 = 18.4),MMP9水平降低(p = 0.015),但IL - 10(p = 0.045)和TGF - β(p = 0.01)水平升高。
这些结果表明,与HNSC分泌组相关的因素可以减轻脊髓损伤后继发性损伤的病理生理过程,并改善大鼠的运动功能结局。